ZOLL first company to receive premarket approval from the FDA on its full portfolio of defibrillators

CHELMSFORD, Mass. — ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, today announced that it is the first company to achieve premarket approval (PMA) by the U.S. Food and Drug Administration (FDA) to continue to market and distribute its full line of defibrillators in the U.S. The list of defibrillators that received PMA approval include the R Series® ...

http://ift.tt/2EAo4Cd